JO3056B1 - تركيبات { 3-[5-(4-كلورو-فينيل )-أ1-بيرلو [2, 3-ب] بيريدين-3-كربونيل ] -2, 4- ثاني فلورو-فينيل } -أميد بروبان-1-حمض سلفونيك واستخداماتها - Google Patents
تركيبات { 3-[5-(4-كلورو-فينيل )-أ1-بيرلو [2, 3-ب] بيريدين-3-كربونيل ] -2, 4- ثاني فلورو-فينيل } -أميد بروبان-1-حمض سلفونيك واستخداماتهاInfo
- Publication number
- JO3056B1 JO3056B1 JOP/2010/0105A JOP20100105A JO3056B1 JO 3056 B1 JO3056 B1 JO 3056B1 JO P20100105 A JOP20100105 A JO P20100105A JO 3056 B1 JO3056 B1 JO 3056B1
- Authority
- JO
- Jordan
- Prior art keywords
- phenyl
- pyrrolo
- difluoro
- carbonyl
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
يتعلق الاختراع الحالي بمشتتات صلبة (solid dispersions)، معقدات جزيئية صلبة (solid molecular complexes)، أملاح (salts) ومتعددات شكل متبلورة (crystalline polymorphs) متضمنا propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16667709P | 2009-04-03 | 2009-04-03 | |
US17605109P | 2009-05-06 | 2009-05-06 | |
EP09175665 | 2009-11-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3056B1 true JO3056B1 (ar) | 2017-03-15 |
Family
ID=54978682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2010/0105A JO3056B1 (ar) | 2009-04-03 | 2010-04-01 | تركيبات { 3-[5-(4-كلورو-فينيل )-أ1-بيرلو [2, 3-ب] بيريدين-3-كربونيل ] -2, 4- ثاني فلورو-فينيل } -أميد بروبان-1-حمض سلفونيك واستخداماتها |
Country Status (4)
Country | Link |
---|---|
HK (2) | HK1168590A1 (ar) |
HR (1) | HRP20151156T1 (ar) |
IL (1) | IL251336B (ar) |
JO (1) | JO3056B1 (ar) |
-
2010
- 2010-04-01 JO JOP/2010/0105A patent/JO3056B1/ar active
-
2012
- 2012-07-30 HK HK12107426.5A patent/HK1168590A1/zh unknown
-
2015
- 2015-10-30 HR HRP20151156TT patent/HRP20151156T1/hr unknown
-
2016
- 2016-05-05 HK HK16105154.3A patent/HK1217195A1/zh unknown
-
2017
- 2017-03-22 IL IL251336A patent/IL251336B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
HK1168590A1 (zh) | 2013-01-04 |
HRP20151156T1 (hr) | 2016-01-01 |
HK1217195A1 (zh) | 2016-12-30 |
IL251336A0 (en) | 2017-05-29 |
IL251336B (en) | 2020-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY172424A (en) | Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof | |
PL2013208T3 (pl) | Pirydyno[3,4-B]pirazynowy | |
PL2595958T3 (pl) | Nowy sposób wytwarzania {3-[5-(4-chlorofenylo)-1 h-pirolo[2,3-b]pirydyno-3-karbonylo]-2,4-difluorofenylo}amidu kwasu propano-1-sulfonowego | |
ZA201202024B (en) | PROPANE-1-SULFONIC ACID {3-[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-b] PYRIDINE-3-CARBONY]-2,4-DIFLUOLOPHENYL}-AMIDE, AS WELL AS USES THEREOF | |
EP2387315A4 (en) | IMIDAZO [1,2-A] PYRIDINES AND IMIDAZO [1,2-B] PYRIDAZINES AS MARK KINASE INHIBITORS | |
PL2155712T3 (pl) | 3-(imidazolilo)-pirazolo[3,4-b]pirydyny | |
PT2124944E (pt) | Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase | |
IL226095A (en) | History of {4– [5– (1-methyl– h1– pyrazole – 4 – ram) - h1– pyrrolo [3,2– b] pyridin-3-ram] pyrimidin-2-yl} reliable and medications containing them | |
ZA201301313B (en) | Herbicidal isoxazolo[5,4-b]pyridines | |
IL207064A0 (en) | Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors | |
JO3056B1 (ar) | تركيبات { 3-[5-(4-كلورو-فينيل )-أ1-بيرلو [2, 3-ب] بيريدين-3-كربونيل ] -2, 4- ثاني فلورو-فينيل } -أميد بروبان-1-حمض سلفونيك واستخداماتها | |
PL2040723T3 (pl) | Bakteria kwasu mlekowego o podwyższonej tolerancji na kwas | |
CY1116983T1 (el) | Συνθεσεις προπανο-1-σουλφονικου οξεος {3-[5-(4-χλωρο-φαινυλ)-1η-πυρρολο[2,3-β]πυριδινο-3-καρβονυλ]-2,4-διφθορο-φαiνυλ}- αμιδιου και χρησεις αυτων | |
BR122020005420B8 (pt) | forma purificada 1 do polimorfo cristalino do composto i | |
EP2459550A4 (en) | R-7- (3-aminomethyl-4-methoxyimino-3-METHYL-PYRROLIDIN-1-YL) -1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro- [1,8] naphthyridine-3 CARBOXYLIC ACID AND L-ASPARINIC ACID SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREFORE FOR AN ANTIMICROBUM | |
UA108842C2 (uk) | Тверда дисперсія, спосіб її одержання, а також композиція і лікарська форма, що її містять |